Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
Go back to Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer| (NASDAQ: CADL) | Delayed: 9.56 -0.3 (3.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.86 | 52 Week High | $ | |||
| Open | $9.86 | 52 Week Low | $ | |||
| Day High | $9.97 | P/E | N/A | |||
| Day Low | $9.46 | EPS | $ | |||
| Volume | 1,012,020 | |||||

